InvestorWire NewsRoom

Article

DGE’s 4th Virtual Clinical Trials Conference
May 3, 2021

DGE’s 4th Virtual Clinical Trials Conference

Monday, May 17, 2021

On Monday, May 17th, 2021, pharma companies, medical vendors, and clinicians are invited to attend the 4th Virtual Clinical Trials conference – the industry’s leading, longest-lasting conference on virtual clinical trials. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The global event company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.

On May 17-18th The 4th Virtual Clinical Trials will increase your ability to execute your decentralized trial, reduce site visits, accelerate timelines and gather data faster.  Hear from top industry experts that will give you the tools to implement remote trials and reduce workloads for clinical trial sites at an accelerated rate.

The 2-day event will feature speeches, keynotes, and discussions from over 25 speakers on the increasing needs, benefits, and potential of virtual clinical trials. The 4th Virtual Clinical Trials Conference offers this unique opportunity to sponsors, and pharma companies to understand the potential of virtual clinical trials and how to remove roadblocks and barriers for collecting and utilizing patient data.

The event will commence with an introductory speech by Craig Lipset, founder of Clinical Innovation Partners. Craig Lipset is a visionary leading the forefront of innovations in clinical research and medicine development. 

Influential Opinion Leaders who will present will include:

  • Angel Soubhie, BAYER, HEAD CLINICAL TRIAL SCIENTISTS – MEDICAL DIRECTOR
  • Jeremy Price, PFIZER, DIRECTOR, CLINICAL OPERATIONS STRATEGIC PARTNERSHIPS
  • Antonieta Sosa, JANSEEN, DIRECTOR, CLINICAL INNOVATION
  • Stephen Lutsch, LEO PHARMA, DIRECTOR, HEAD OF REVOLUTIONIZE CLINICAL TRIALS
  • Maimah Karmo, TIGERLILY FOUNDATION, CEO, PATIENT ADVOCATE

Clinicians, trial managers, clinical data experts, vendors, pharma companies, and scientists should leverage the opportunity offered by the event, as it is will showcase:

  • A roadmap for turning urgent responses to COVID into permanent new processes that will keep your momentum going
  • Best practice on updating SOPs for these unprecedented problems
  • Strategies to maintain patient centricity, safety, and feedback throughout the trial
  • An up-to-date review of new assessments and expectations from regulators
  • Key techniques for collaborating around new data standards with service providers

COVID-19 has increased the need for virtual clinical trials. The key theme and the objective of the conference is to discuss and discover the innovation, recruitment, and application of virtual clinical trials to a wider pharma sector while keeping the patient experience in mind.

For tickets to the event, please visit https://ibn.fm/QduhD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).